Impact of age, Recurrence Score (RS) and ovarian function suppression (OFS) on endocrine response to short preoperative endocrine therapy (ET): Analysis of ADAPT and ADAPTcycle trials
Presentation from ESMO 2022, Paris
LUMINA efficacy presentation from ASCO 2022, Chicago
MonarchE efficacy presentation from ESMO Breast Cancer 2022, Berlin